Title: Paul B Tiege: Innovator in Vascular Occlusion Technologies
Introduction
Paul B Tiege is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of medical technology, particularly in the area of vascular occlusion. His innovative work focuses on methods and compositions that enhance the targeting and delivery of solid-phase platelet-dependent vascular occlusion agents.
Latest Patents
Paul B Tiege holds a patent titled "Compositions And Methods For Producing Vascular Occlusion Using A Solid-Phase Platelet Binding Agent." This invention relates to methods and compositions for targeting and delivering solid-phase platelet-dependent vascular occlusion agents. The technology involves particles, coils, or stents coated with platelet binding agents that are directed to target vasculature, such as that of solid tumor masses or AV-malformations. The solid-phase agent binds and activates platelets, leading to the rapid formation of a platelet-mediated thrombus around the solid-phase agent, resulting in vessel occlusion. Notably, he has 0 patents registered under his name.
Career Highlights
Paul B Tiege is associated with Imbiotechnologies Ltd, where he continues to develop innovative solutions in the medical field. His work is characterized by a commitment to advancing technologies that improve patient outcomes in vascular treatments.
Collaborations
Throughout his career, Paul has collaborated with notable professionals, including Michael William Stewart and Roland Henryk Person. These collaborations have contributed to the development of cutting-edge technologies in the medical sector.
Conclusion
Paul B Tiege is a dedicated inventor whose work in vascular occlusion technologies showcases his innovative spirit and commitment to improving medical treatments. His contributions are significant in the ongoing evolution of medical technology.